Author

Year

Benign

Borderline

Malignant

Mohammed et al.

2015

100%

72.7%

88.4%

Malipatil & Crasta

2013

99.3%

86.66

84.9%

Suprasert et al.

2008

100%

84.2

92%

Ilvan et al.

2005

100%

87%

87%